| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |